Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Beck

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Molecular and Biochemical Parasitology|December 1, 1990
Nutritional requirements of wild-type and folate transport-deficient Leishmania donovani for pterins and folatesJ T Beck, B Ullman
The Journal of Biological Chemistry|February 15, 1987
Genetic demonstration of bidirectionality in the high affinity purine base transporter of mutant mouse S49 cellsJ T Beck, B Ullman
Biochemistry|August 22, 1989
Affinity labeling of the folate-methotrexate transporter from Leishmania donovaniJ T Beck, B Ullman
Molecular and Biochemical Parasitology|November 1, 1991
Biopterin conversion to reduced folates by Leishmania donovani promastigotesJ T Beck, B Ullman
Journal of Personality Assessment|June 1, 1983
Rorschach developmental level and its relationship to subsequent psychiatric treatmentJ T Beck, J Worland
Molecular and Biochemical Parasitology|August 1, 1993
The hypoxanthine-guanine-xanthine phosphoribosyltransferase from Tritrichomonas foetus has unique propertiesJ T Beck, C C Wang
Bioseparation|March 29, 2000
Direct coupling of expanded bed adsorption with a downstream purification stepJ T Beck, B Williamson, B Tipton
Experimental Parasitology|February 1, 1994
Cloning, sequencing, and structural analysis of the DNA encoding inosine monophosphate dehydrogenase (EC 1.1.1.205) from Tritrichomonas foetusJ T Beck, S Zhao, C C Wang
Molecular Immunology|December 1, 1994
Generation of soluble interleukin-1 receptor from an immunoadhesin by specific cleavageJ T Beck, S A Marsters, R J Harris, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 9, 2007
Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211)D S Alberts, P Y Liu, S P Wilczynski, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Molecular and Biochemical Parasitology|December 1, 1990
Nutritional requirements of wild-type and folate transport-deficient Leishmania donovani for pterins and folatesJ T Beck, B Ullman
The Journal of Biological Chemistry|February 15, 1987
Genetic demonstration of bidirectionality in the high affinity purine base transporter of mutant mouse S49 cellsJ T Beck, B Ullman
Biochemistry|August 22, 1989
Affinity labeling of the folate-methotrexate transporter from Leishmania donovaniJ T Beck, B Ullman
Molecular and Biochemical Parasitology|November 1, 1991
Biopterin conversion to reduced folates by Leishmania donovani promastigotesJ T Beck, B Ullman
Journal of Personality Assessment|June 1, 1983
Rorschach developmental level and its relationship to subsequent psychiatric treatmentJ T Beck, J Worland
Molecular and Biochemical Parasitology|August 1, 1993
The hypoxanthine-guanine-xanthine phosphoribosyltransferase from Tritrichomonas foetus has unique propertiesJ T Beck, C C Wang
Bioseparation|March 29, 2000
Direct coupling of expanded bed adsorption with a downstream purification stepJ T Beck, B Williamson, B Tipton
Experimental Parasitology|February 1, 1994
Cloning, sequencing, and structural analysis of the DNA encoding inosine monophosphate dehydrogenase (EC 1.1.1.205) from Tritrichomonas foetusJ T Beck, S Zhao, C C Wang
Molecular Immunology|December 1, 1994
Generation of soluble interleukin-1 receptor from an immunoadhesin by specific cleavageJ T Beck, S A Marsters, R J Harris, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 9, 2007
Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211)D S Alberts, P Y Liu, S P Wilczynski, et al.
Pageof 2